Frank R. Hunt
BioStrategies, Inc.
Currently, President, BioStrategies, Inc., a new enterprise development firm specializing in the early-stage, strategic development of university-based technologies and associated commercial opportunities within the life sciences industry. Examples of companies founded and managed include ErythroGen, Inc. (artificial blood substitute and gene therapy) and Sláinte Bioceuticals, Inc. (chemotherapeutic agents), serving as President/CEO of both.